1255871-41-0

Basic information

• Product Name: 1-(5-broMopyridin-3-yl)cyclopropanecarboxylic acid
• Synonyms: 1-(5-broMopyridin-3-yl)cyclopropanecarboxylic acid
• CAS NO: 1255871-41-0
• Molecular Formula: C10H10BrNO2
• Molecular Weight: 256.099
• Mol File: 1255871-41-0.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 311.0±37.0 °C(Predicted)
• Density: 1.572±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1-(5-broMopyridin-3-yl)cyclopropanecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-broMopyridin-3-yl)cyclopropanecarboxylic acid(1255871-41-0)
• EPA Substance Registry System: 1-(5-broMopyridin-3-yl)cyclopropanecarboxylic acid(1255871-41-0)

Safety Data

• Hazardous Substances Data: 1255871-41-0(Hazardous Substances Data)

Upstream product

• 106-93-4 ethylene dibromide 
• 118650-08-1 (5-bromo-pyridin-3-yl)-acetic acid methyl ester 
• 186581-53-3 diazomethane 
• 1256038-40-0 1-(5-bromo-3-pyridinyl)cyclopropanecarboxylic acid 
• 39891-12-8 5-bromo-3-pyridineacetic acid 

Downstream Products

• 1255871-43-2 potassium 1-(5-bromopyridin-3-yl)cyclopropanecarboxylate 
• 1255871-47-6 4-(5-(1-aminocyclopropyl)pyridin-3-yl)-2-chlorobenzonitrile 
• 1255871-45-4 1-(5-(3-chloro-4-cyanophenyl)pyridin-3-yl)cyclopropanecarboxylic acid 
• 1255870-31-5 N-(1-(5-(3-chloro-4-cyanophenyl)pyridin-3-yl)cyclopropyl)ethanesulfonamide 
• 1369503-74-1 [1-(5-bromo-3-pyridinyl)cyclopropyl]methanol 
• 1256038-40-0 1-(5-bromo-3-pyridinyl)cyclopropanecarboxylic acid 

Relevant articles and documents

PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D MEDICAL DISORDERS

Compounds, methods of use, and processes for making inhibitors of complement factor D or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade. The inhibitors of factor D described herein reduce the excessive activation of complement.

NEW DIHYDROQUINOLINE-2-ONE DERIVATIVES

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4? R5, R6, R7, A1, A2 and A3 are as described herein, compositions including the compounds and methods of using the compounds.

ARYL PYRIDINE AS ALDOSTERONE SYNTHASE INHIBITORS

The present invention provides a compound of Formula (I); a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.